Sigilon Therapeutics, Inc. Stock
Equities
SGTX
US82657L2060
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Director of Finance/CFO | 58 | 19-10-31 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Gordon Brooks
BRD | Director/Board Member | - | 23-08-10 |
1st Jan change | Capi. | |
---|---|---|
-1.78% | 41.36B | |
+45.21% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |